Reviewed,
UniProtKB/Swiss-Prot P51811 (XK_HUMAN)
Last modified
May 5, 2009.
Version 73.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Membrane transport protein XK Alternative name(s): Kx antigen Kell complex 37 kDa component XK-related protein 1 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 444 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | May be involved in sodium-dependent transport of neutral amino acids or oligopeptides. |
| Subunit structure | Heterodimer with Kell; disulfide-linked. Ref.7 |
| Subcellular location | Membrane; Multi-pass membrane protein Potential. |
| Tissue specificity | High levels in skeletal muscle, heart, brain, and pancreas; low levels in placenta, lung, liver, and kidney. |
| Post-translational modification | Not glycosylated. Ref.6 |
| Polymorphism | XK is responsible for the Kx blood group system. |
| Involvement in disease | Defects in XK are the cause of McLeod syndrome (MLS) [MIM:314850]. It is an X-linked multisystem disorder characterized by late onset abnormalities in the neuromuscular and hematopoietic systems. Ref.9 Ref.10 Ref.11 |
| Sequence similarities | Belongs to the XK family. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Amino-acid transport Transport |
| Cellular component | Membrane |
| Disease | Disease mutation |
| Domain | Transmembrane |
| Molecular function | Blood group antigen |
| PTM | Disulfide bond Phosphoprotein |
| Technical term | Direct protein sequencing |
| Gene Ontology (GO) | |
| Biological process | amino acid transport Inferred from electronic annotation. Source: UniProtKB-KW |
| Cellular component | integral to membrane Ref.1 Traceable author statement. Source: HGNC |
| Molecular function | protein binding Ref.6 Inferred from physical interaction. Source: HGNC transporter activity Ref.1Traceable author statement. Source: ProtInc |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 444 | 444 | Membrane transport protein XK | PRO_0000190767 | |||||
Regions | |||||||||
| Topological domain | 1 – 2 | 2 | Cytoplasmic Potential | ||||||
| Transmembrane | 3 – 23 | 21 | Potential | ||||||
| Topological domain | 24 – 37 | 14 | Extracellular Potential | ||||||
| Transmembrane | 38 – 58 | 21 | Potential | ||||||
| Topological domain | 59 – 68 | 10 | Cytoplasmic Potential | ||||||
| Transmembrane | 69 – 89 | 21 | Potential | ||||||
| Topological domain | 90 – 140 | 51 | Extracellular Potential | ||||||
| Transmembrane | 141 – 161 | 21 | Potential | ||||||
| Topological domain | 162 – 171 | 10 | Cytoplasmic Potential | ||||||
| Transmembrane | 172 – 192 | 21 | Potential | ||||||
| Topological domain | 193 – 208 | 16 | Extracellular Potential | ||||||
| Transmembrane | 209 – 229 | 21 | Potential | ||||||
| Topological domain | 230 – 235 | 6 | Cytoplasmic Potential | ||||||
| Transmembrane | 236 – 256 | 21 | Potential | ||||||
| Topological domain | 257 – 277 | 21 | Extracellular Potential | ||||||
| Transmembrane | 278 – 298 | 21 | Potential | ||||||
| Topological domain | 299 – 317 | 19 | Cytoplasmic Potential | ||||||
| Transmembrane | 318 – 338 | 21 | Potential | ||||||
| Topological domain | 339 – 349 | 11 | Extracellular Potential | ||||||
| Transmembrane | 350 – 370 | 21 | Potential | ||||||
| Topological domain | 371 – 444 | 74 | Cytoplasmic Potential | ||||||
Amino acid modifications | |||||||||
| Modified residue | 63 | 1 | Phosphoserine Ref.8 | ||||||
| Disulfide bond | 347 | Interchain (with C-72 in Kell) Ref.7 | |||||||
Natural variations | |||||||||
| Natural variant | 222 | 1 | R → G in MLS. Ref.10 | VAR_013817 | |||||
| Natural variant | 294 | 1 | C → R in MLS. Ref.9 | VAR_013818 | |||||
| Natural variant | 327 | 1 | E → K in MLS; atypical without hematologic, neuromuscular, or cerebral involvement; protein seems functional. Ref.11 | VAR_023581 | |||||
Experimental info | |||||||||
| Mutagenesis | 347 | 1 | C → S: Loss of Kell-XK complex. Ref.7 | ||||||
| Sequence conflict | 248 | 1 | F → L Ref.3 | ||||||
| Sequence conflict | 248 | 1 | F → L Ref.5 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein." Ho M., Chelly J., Carter N., Danek A., Crocker P., Monaco A.P. Cell 77:869-880(1994) [PubMed: 8004674] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | Ho M. Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases Cited for: SEQUENCE REVISION TO 204-205. |
| [3] | "A superfamily of XK-related genes (XRG) widely expressed in vertebrates and invertebrates." Huang C.-H., Chen Y. Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [4] | SeattleSNPs variation discovery resource Submitted (MAY-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Testis. |
| [6] | "Purification and partial characterization of the erythrocyte Kx protein deficient in McLeod patients." Khamlichi S., Bailly P., Blanchard D., Goossens D., Cartron J.-P., Bertrand O. Eur. J. Biochem. 228:931-934(1995) [PubMed: 7737196] [Abstract] Cited for: PROTEIN SEQUENCE OF 1-22, LACK OF GLYCOSYLATION. |
| [7] | "Association of XK and Kell blood group proteins." Russo D., Redman C., Lee S. J. Biol. Chem. 273:13950-13956(1998) [PubMed: 9593744] [Abstract] Cited for: SUBUNIT, DISULFIDE BOND, MUTAGENESIS OF CYS-347. |
| [8] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-63, MASS SPECTROMETRY. Tissue: Epithelium. |
| [9] | "McLeod neuroacanthocytosis: genotype and phenotype." Danek A., Rubio J.P., Rampoldi L., Ho M., Dobson-Stone C., Tison F., Symmans W.A., Oechsner M., Kalckreuth W., Watt J.M., Corbett A.J., Hamdalla H.H., Marshall A.G., Sutton I., Dotti M.T., Malandrini A., Walker R.H., Daniels G., Monaco A.P. Ann. Neurol. 50:755-764(2001) [PubMed: 11761473] [Abstract] Cited for: VARIANT MLS ARG-294. |
| [10] | "Point mutations causing the McLeod phenotype." Russo D.C., Lee S., Reid M.E., Redman C.M. Transfusion 42:287-293(2002) [PubMed: 11961232] [Abstract] Cited for: VARIANT MLS GLY-222. |
| [11] | "McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement." Jung H.H., Hergersberg M., Vogt M., Pahnke J., Treyer V., Rothlisberger B., Kollias S.S., Russo D., Frey B.M. Transfusion 43:928-938(2003) [PubMed: 12823753] [Abstract] Cited for: VARIANT MLS LYS-327. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| Z32684 mRNA. Translation: CAA83632.2. AY534238 mRNA. Translation: AAT07087.1. DQ062746 Genomic DNA. Translation: AAY43132.1. BC036019 mRNA. Translation: AAH36019.1. | |
| IPI | IPI00020896. |
| PIR | I39294. |
| RefSeq | NP_066569.1. |
| UniGene | Hs.78919 |
3D structure databases | |
| ModBase | Search... |
Protein family/group databases | |
| TCDB | 9.B.5.1.1. KX blood-group antigen (KXA) family. |
Proteomic databases | |
| PRIDE | P51811. |
Genome annotation databases | |
| Ensembl | ENSG00000047597. Homo sapiens. [Contig view] |
| GeneID | 7504. |
| KEGG | hsa:7504. |
Organism-specific databases | |
| GeneCards | GC0XP037430. |
| H-InvDB | HIX0028449. |
| HGNC | HGNC:12811. XK. |
| MIM | 314850. gene+phenotype. |
| Orphanet | 59306. McLeod neuroacanthocytosis syndrome. |
| PharmGKB | PA33162. |
| GenAtlas | Search... |
Phylogenomic databases | |
| HOGENOM | P51811. |
| HOVERGEN | P51811. |
| OMA | P51811. GKLFTHR. |
Gene expression databases | |
| ArrayExpress | P51811. |
| Bgee | P51811. |
| CleanEx | HS_XK. |
| GermOnline | ENSG00000047597. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR018629. Membr_transp_prot_XK-like. [Graphical view] |
| Pfam | PF09815. XK-related. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other Resources | |
| NextBio | 29381. |
| SOURCE | Search... |
Entry information
| Entry name | XK_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P51811 Secondary accession number(s): Q4TTN6, Q8IUK6, Q9UC77 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Blood group antigen proteins Nomenclature of blood group antigens and list of entries |
| Human chromosome X Human chromosome X: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with


